GPX1 and metabolic dysfunction-associated steatotic liver disease: While protection from NAFLD induced by hepatocyte-specific deletion of GPX1 and HMOX1 in mice is a proof of concept that excessive antioxidant function can promote NAFLD, no therapeutic strategies and trials aimed to decrease antioxidant activity in human livers.